SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in YayYo, Inc. of Class Action Lawsuit and Upcoming Deadline – YAYO.
Pomerantz LLP announces that a class action lawsuit has been filed against YayYo, Inc. and certain of its officers. The class action, filed in United States District Court for the Central District of California, and docketed under 20-cv-08591, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise, … Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in YayYo, Inc. of Class Action Lawsuit and Upcoming Deadline – YAYO. Continue Reading


Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fulton Financial Corporation on behalf of Fulton stockholders. Our investigation concerns whether Fulton has violated the federal securities laws and/or engaged in other unlawful business practices. On September 28, 2020, the U.S. Securities and Exchange Commission (“SEC”) announced …
Hagens Berman urges Precigen, Inc. investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims. Precigen, Inc. (PGEN) Investigation: The investigation focuses on Precigen’s claims about its conversion of relatively inexpensive natural gas into more expensive industrial chemicals using its methane bioconversion …
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Las Vegas Sands Corp. . On September 16, 2020, Bloomberg reported that the Company has retained a law firm to investigate employee transfers of more than $1 billion in …
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Vaxart, Inc. In early 2020, the Company, which focuses on vaccination research and development, began working on a vaccine for COVID-19. Through mid-2020, the Company consistently …